13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

Page 3 of 9 – SEC Filing

 

 

CUSIP
No
.
713661502   Page
3 of 9

 

1

NAME
OF REPORTING PERSONS
Tappan Street Partners Fund L.P.

 

I.R.S.
IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 45- 2663014

 
2 CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)

(b)

3 SEC
USE ONLY
 
4

CITIZENSHIP
OR PLACE OF ORGANIZATION

Delaware,
United States of America

 

NUMBER
OF
SHARES

BENEFICIALLY
OWNED BY

EACH
REPORTING

PERSON
WITH:

5

SOLE
VOTING POWER

0

 
6

SHARED
VOTING POWER

1,540,000

 
7

SOLE
DISPOSITIVE POWER

0

 
8

SHARED
DISPOSITIVE POWER

1,540,000

 
9

AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,540,000

 
10 CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
11

PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9

3.42%†

 
12

TYPE
OF REPORTING PERSON

PN

 
         

†Based
on a total of 45,069,188 Shares outstanding of the Issuer as of July 11, 2017, as set forth in the Issuer’s most recent
Form 10-K, filed July 14, 2017.

 

 

Follow Avid Bioservices Inc. (NASDAQ:CDMO)